Evaluation of optimal acquisition duration or injected activity for pediatric18F-FDG PET/CT

Journal of Nuclear Medicine

Volumn 52, Issue 7, 2011, Pages 1028-1034

  Alessio, Adam M ^a,b   Sammer, Marla ^c   Phillips, Grace S ^a,b   Manchanda, Vivek ^a   Mohr, Brandt C ^a   Parisi, Marguerite T ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c TC Thompson Children's Hospital   (United States)

Author keywords

18F FDG activity; Acquisition protocols; Dosimetry; Pediatric PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; ARTIFACT REDUCTION; BODY WEIGHT; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSIMETRY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEPATOBLASTOMA; HUMAN; IMAGE ANALYSIS; LYMPHOMA; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOACTIVITY; SARCOMA; SCHOOL CHILD; WHOLE BODY CT; WHOLE BODY PET;

ADOLESCENT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT; INJECTIONS; MALE; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79960308808     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.086579     Document Type: Article

References (22)

1. Treves ST, Davis RT, Fahey FH. Administered radiopharmaceutical doses in children: a survey of 13 pediatric hospitals in North America. J Nucl Med. 2008;49:1024-1027. (Pubitemid 351793445)
2. Lassmann M, Biassoni L, Monsieurs M, Franzius C. The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging. 2008;35:1666-1668.
3. Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging. 2007;34:796-798. (Pubitemid 46669372)
4. Gelfand MJ, Parisi MT, Treves ST. Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines. J Nucl Med. 2011;52:318-322.
5. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: National Academies Press; 2006. Available at: http://www.nap.edu/catalog.php?record-id=11340. Accessed June 13, 2011.
6. Fahey FH. Dosimetry of pediatric PET/CT. J Nucl Med. 2009;50:1483-1491.
7. Barrington SF, Begent J, Lynch T, et al. Guidelines for the use of PET-CT in children. Nucl Med Commun. 2008;29:418-424. (Pubitemid 351507534)
8. Kaste SC. Issues specific to implementing PET-CT for pediatric oncology: what we have learned along the way. Pediatr Radiol. 2004;34:205-213. (Pubitemid 38396974)
9. Stauss J, Franzius C, Pfluger T, et al. Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging. 2008;35:1581-1589.
10. Alessio AM, Kinahan PE, Manchanda V, Ghioni V, Aldape L, Parisi MT. Weight-based, low-dose pediatric whole-body PET/CT protocols. J Nucl Med. 2009;50:1570-1577.
11. Jacobs F, Thierens H, Piepsz A, et al. Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. Eur J Nucl Med Mol Imaging. 2005;32:581-588. (Pubitemid 41217418)
12. Accorsi R, Karp JS, Surti S. Improved dose regimen in pediatric PET. J Nucl Med. 2010;51:293-300.
13. Watson CC, Casey ME, Bendriem B, et al. Optimizing injected dose in clinical PET by accurately modeling the counting-rate response functions specific to individual patient scans. J Nucl Med. 2005;46:1825-1834. (Pubitemid 46196644)
14. Boone JM, Geraghty EM, Seibert JA, Wootton-Gorges SL. Dose reduction in pediatric CT: a rational approach. Radiology. 2003;228:352-360. (Pubitemid 36910072)
15. Watson CC. Injected dose in pediatric PET. J Nucl Med. 2010;51:1657.
16. Halpern BS, Dahlbom M, Auerbach MA, et al. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study. J Nucl Med. 2005;46:603-607. (Pubitemid 41716404)
17. Halpern BS, Dahlbom M, Quon A, et al. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. J Nucl Med. 2004;45:797-801. (Pubitemid 47618559)
18. Teras M, Tolvanen T, Johansson JJ, Williams JJ, Knuuti J. Performance of the new generation of whole-body PET/CT scanners: Discovery STE and Discovery VCT. Eur J Nucl Med Mol Imaging. 2007;34:1683-1692. (Pubitemid 47476933)
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174. (Pubitemid 8054849)
20. Strother SC, Casey ME, Hoffman EJ. Measuring PET scanner sensitivity: relating countrates to image signal-to-noise ratios using noise equivalents counts. IEEE Trans Nucl Sci. 1990;37:783-788. (Pubitemid 20713969)
21. Lartizien C, Comtat C, Kinahan PE, Ferreira N, Bendriem B, Trebossen R. Optimization of injected dose based on noise equivalent count rates for 2- and 3-dimensional whole-body PET. J Nucl Med. 2002;43:1268-1278. (Pubitemid 34988777)
22. Badawi RD, Dahlbom M. NEC: some coincidences are more equivalent than others. J Nucl Med. 2005;46:1767-1768. (Pubitemid 46196635)